# Fibrinogen human

## Haemocomplettan P inj 1gm/vial

| TAH Drug Code      | [IHMCP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHMCP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Bleeding disorder. 1) Congenital hypo-, dys-, or afibrinogenemia. 2) Acquired hypofibrinogenemia caused by the following symptoms: a. Severe liver parenchymal injury leading to synthesis disorder. b. Excessive consumption due to disseminated intravascular coagulation (DIC) and hyperfibrinolysis response.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Dosage for replacement therapy and duration should be based on disease severity, bleeding location and extent, and the patient's clinical condition. To calculate the patient's dosage, measure functional fibrinogen levels. Individual dosing and frequency should be determined based on routine measurements of plasma fibrinogen concentration, and continuous monitoring of the patient's clinical condition and use of other replacement therapies. Normal plasma fibrinogen: 1.5-4.5g/L. Critical plasma fibrinogen: 0.5-1.0g/L or below may result in bleeding. (1) For patients with congenital hypo-, dys-, or afibrinogenemia and known bleeding tendencies for prophylaxis: - Preventive treatment is recommended to raise fibrinogen levels to 1 g/L to ensure safe hemostasis and maintain fibrinogen levels >0.5g/L until complete wound healing. - For surgical or bleeding event treatment: Fibrinogen dosage (mg/kg) = [(Target concentration in g/L) - (Measured concentration in g/L)] / 0.017 (g/L per mg/kg). - Appropriate subsequent dosages should be based on the patient's clinical condition and laboratory reports. - Half-life of fibrinogen is 3-4 days. Repeated administration is usually unnecessary in the absence of consumption. (2) For bleeding treatment: Adults: 1-2g (or 30 mg/kg) as needed, followed by additional transfusions. Severe bleeding: 4-8g may be required. Children: 20-30mg/kg. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Contraindicated in individuals allergic to the active ingredient or any excipients. Avoid in cases of thrombosis or myocardial infarction, unless in extremely severe and life-threatening bleeding situations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Nausea (>5%), Vomiting (>5%), Thrombocytosis (>5%), Headache (>1%), Fever (>1%) Serious: Myocardial infarction, Arterial thrombosis, Deep venous thrombosis, Thromboembolic disorder, Anaphylaxis, Hypersensitivity reaction, Pulmonary embolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/fibrinogen-concentrate-from-human-plasma-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

